USPTO 2015–2025 USPTO PatentsView US Corporation

Movano Inc.

USPTO PatentsView assignee record - 35 granted patents across 10 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Movano ranks #9,084 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 10 technology areas.

#9,084
of 49,997 US assignees by volume
Top 7%
by Innovation Score (55.8/100)
20.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R9084 · US Corporation #9,084 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 35 grants
  • UPPER-Q #9,084/49,997
  • PHOTO-FINISH Mainstay Medical
  • CPC-FOCUS A61B · 10 areas
  • INNOV-PAR 55.8/100
  • CLAIMS-DENSE 20.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Mainstay Medical Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Movano

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Movano's Innovation Score is 55.8/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Movano's grants concentrate

Movano Inc. is a focused PatentsView assignee: 10 CPC subclasses with 91.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (10 grants) versus a trough of 2 in 2020. By volume, Movano sits between Mainstay Medical Limited and National Institute OF Meteorological Sciences.

Movano's three-year grant acceleration

Movano Inc. shows 29 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Movano's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Movano holds 35 patents at rank #9,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Movano

By rank, the assignees closest to #9,084 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Movano's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Movano, neither rank-band nor same-CPC leaders (those blocks stay above).

Movano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20202021202220232024 9
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Movano Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 5.7%
2021 4 11.4%
2022 10 28.6%
2023 10 28.6%
2024 9 25.7%

Where it ranks

Overall rank by patents

#9,084

of 49,997 tracked assignees

Innovation Score

55.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Movano Inc.'s patent record in context - here's where to go next.

  • Movano Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 91.4% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #9,084 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Movano Inc. against Mainstay Medical Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 55.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.